| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |